EUVIMEDEUVIMED entdecken
Crossref

Recombinant GM-CSF enhances the bactericidal ability of PMNs by increasing intracellular IL-1β and improves the prognosis of secondary Pseudomonas aeruginosa pneumonia in sepsis

Fuquan Tu iD, Lili Pan, Wenwei Wu, Yuanhua Cai, Jinggang Li, Xuechun Wang, Xiaolin Lai, Zhixiang Chen, Luya Ye, Shaoyuan Wang

Journal of Leukocyte Biology · 26.10.2023 · 114 (5) · 443-458

DOI: 10.1093/jleuko/qiad088 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Leukocyte Biology, online erschienen am 25.07.2023. Verfasst von Fuquan Tu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Fujian Provincial Key Laboratory of Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, 2…. Hauptthemen laut MEDLINE: Granulocyte-Macrophage Colony-Stimulating Factor, Sepsis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fujian Provincial Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study tested the hypothesis that recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) enhances polymorphonuclear neutrophils (PMNs) via interleukin (IL)-1β to improve the prognosis of secondary infection in sepsis. The latter stage of sepsis is prone to induce immunosuppression, resulting in secondary fatal infections. Recombinant GM-CSF has become a way for sepsis-induced immunosuppression due to its immunomodulatory effect. However, the functional impact of GM-CSF on PMNs in sepsis remains obscure. This study aimed to study the role of recombinant GM-CSF on the bactericidal ability of PMNs in septic mice, assessing its effect on the prognosis of secondary pneumonia, and explore the mechanism of recombinant GM-CSF by intervening PMNs in patients with sepsis. The C57BL/6J sepsis mouse model was induced by cecal ligation and puncture. Recombinant murine GM-CSF (rmGM-CSF) was used in vivo when mice developed immunosuppression, which was characterized by abnormal bactericidal function of PMNs in peripheral blood. rmGM-CSF improved the prognosis of secondary pneumonia and reversed the function of PMNs. PMNs isolated by Percoll from septic patients were treated by recombinant human GM-CSF (rhGM-CSF) in vitro. The expression of CD11b, reactive oxygen species, phagocytosis, and neutrophil extracellular trap release in PMNs were enhanced by rhGM-CSF treatments. Whole-transcriptomic sequencing of mouse PMNs indicated that recombinant GM-CSF increased the expression of Il1b gene in PMNs. Blocking and inhibiting IL-1β release effectively counteracted the enhancing effect of GM-CSF on the bactericidal function of PMNs. rmGM-CSF enhances the bactericidal function of PMNs in vivo and improves the prognosis of secondary pneumonia in septic mice, and recombinant GM-CSF increases IL-1β precursor reserves, which, if stimulated, can rapidly enhance the bactericidal capacity of PMNs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Granulocyte-Macrophage Colony-Stimulating FactorSepsisHumansMiceAnimalsNeutrophilsPseudomonas aeruginosaGranulocyte Colony-Stimulating FactorMice, Inbred C57BLRecombinant ProteinsPrognosis

Stichwörter der Autor:innen

immunosuppressioninterleukin-1βpolymorphonuclear neutrophilsrecombinant granulocyte-macrophage colony stimulating factorsepsis

Substanzen

Granulocyte-Macrophage Colony-Stimulating FactorGranulocyte Colony-Stimulating FactorRecombinant Proteins

Autor:innen und Institutionen

  • Department of Hematology, Fujian Provincial Key Laboratory of Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou 350001, Fujian, China.
  • Department of Emergency Intensive Care Unit, Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou 350001, Fujian, China.
  • Union Clinical Medical Colleges, Fujian Medical University, 29 Xinquan Road, Fuzhou 350001, Fujian, China.

ORCID-Profile: Fuquan Tu

Förderung

  • National Natural Science Foundation of China
  • Fujian Provincial Natural Science Foundation of China

Zitieren

APA

Tu, F., Pan, L., Wu, W., Cai, Y., Li, J., Wang, X., Lai, X., Chen, Z., Ye, L., & Wang, S. (2023). Recombinant GM-CSF enhances the bactericidal ability of PMNs by increasing intracellular IL-1β and improves the prognosis of secondary Pseudomonas aeruginosa pneumonia in sepsis. Journal of Leukocyte Biology, 114(5), 443-458. https://doi.org/10.1093/jleuko/qiad088

Vancouver

Tu F, Pan L, Wu W, Cai Y, Li J, Wang X, et al. Recombinant GM-CSF enhances the bactericidal ability of PMNs by increasing intracellular IL-1β and improves the prognosis of secondary Pseudomonas aeruginosa pneumonia in sepsis. Journal of Leukocyte Biology. 2023;114(5):443-458. doi:10.1093/jleuko/qiad088

BibTeX
@article{Tu2023,
  author = {Tu, Fuquan and Pan, Lili and Wu, Wenwei and Cai, Yuanhua and Li, Jinggang and Wang, Xuechun and Lai, Xiaolin and Chen, Zhixiang and Ye, Luya and Wang, Shaoyuan},
  title = {Recombinant GM-CSF enhances the bactericidal ability of PMNs by increasing intracellular IL-1β and improves the prognosis of secondary Pseudomonas aeruginosa pneumonia in sepsis},
  journal = {Journal of Leukocyte Biology},
  year = {2023},
  volume = {114},
  number = {5},
  pages = {443--458},
  doi = {10.1093/jleuko/qiad088}
}
Kostenlos starten →